Keros Therapeutics, Inc. Deferred Tax Assets, Goodwill and Intangible Assets
Keros Therapeutics, Inc. (KROS) had Deferred Tax Assets, Goodwill and Intangible Assets of $0 as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2025-02-26
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $0.00.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $0.00.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $115.00K.
- 2021-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $127.00K.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2022-12-31 | $115.00K 10-K · filed 2024-02-28 |
| 2021-12-31 | $127.00K 10-K · filed 2023-03-03 |
| 2020-12-31 | $139.00K 10-K · filed 2022-03-09 |
| 2019-12-31 | $151.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |